Drugs for Elevated Low-Density Lipoprotein Cholesterol
Inhibitors of 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase, also known as statins, are competitive inhibitors of the rate-limiting step of hepatic cholesterol synthesis. This leads to a reduction in hepatocyte cholesterol…